Vor Biopharma Inc. (VOR)

Vor Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	160.46	81.95	31.36	57.71	119.8	48.54
Short-Term Investments	10	9.98	105.82	172.54	87.67	-
Cash & Short-Term Investments	170.46	91.93	137.18	230.25	207.47	48.54
Cash Growth	171.40%	-32.99%	-40.42%	10.98%	327.43%	650.68%
Prepaid Expenses	0.75	4.2	3.15	4.37	4.84	0.47
Other Current Assets	1.28	0.38	0.48	2.34	2.09	0.1
Total Current Assets	172.49	96.51	140.8	236.95	214.4	49.11
Property, Plant & Equipment	3.31	41.59	50.1	57.08	22.52	21.85
Other Long-Term Assets	0.44	4.8	7.23	5.34	5.67	4.96
Total Assets	176.24	142.89	198.13	299.37	242.59	75.91
Accounts Payable	0.89	1.51	0.82	1.77	1.55	2.36
Accrued Expenses	17.7	12.89	10.93	8.08	6.34	6.26
Current Portion of Leases	0.25	4.22	3.83	3.27	1.84	0.86
Other Current Liabilities	-	-	-	-	0.43	0.72
Total Current Liabilities	18.84	18.61	15.57	13.12	10.15	10.21
Long-Term Leases	2.81	27.62	31.83	35.64	16.17	17.43
Total Liabilities	2,402	46.23	47.4	48.76	26.33	27.64
Common Stock	0.02	0.01	0.01	0.01	0	0
Additional Paid-In Capital	650.32	553.62	490.87	473.59	346.38	2.16
Retained Earnings	-2,876	-456.99	-340.08	-222.22	-130.12	-61.22
Comprehensive Income & Other	0.01	0.02	-0.08	-0.77	-	-
Total Common Equity	-2,225	96.66	150.72	250.61	216.26	-59.07
Shareholders' Equity	-2,225	96.66	150.72	250.61	216.26	48.27
Total Liabilities & Equity	176.24	142.89	198.13	299.37	242.59	75.91
Total Debt	3.06	31.83	35.66	38.91	18.01	18.29
Net Cash (Debt)	167.4	60.1	101.52	191.33	189.46	30.25
Net Cash Growth	458.85%	-40.80%	-46.94%	0.99%	526.38%	367.77%
Net Cash Per Share	29.51	17.49	30.22	96.75	113.33	2831.23
Filing Date Shares Outstanding	10.41	6.24	3.41	3.32	1.87	1.86
Total Common Shares Outstanding	9.03	6.24	3.39	3.3	1.86	0.03
Working Capital	153.65	77.9	125.23	223.83	204.25	38.9
Book Value Per Share	-246.54	15.49	44.40	75.95	116.35	-2338.84
Tangible Book Value	-2,225	96.66	150.72	250.61	216.26	-59.07
Tangible Book Value Per Share	-246.54	15.49	44.40	75.95	116.35	-2338.84
Machinery	0.27	17.15	17.4	15.64	8.77	5.45
Construction In Progress	-	0.04	0.15	1.04	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q